Asymptomatic Benign Papilloma Without Atypia Diagnosed at Ultrasonography-Guided 14-Gauge Core Needle Biopsy: Which Subgroup can be Managed by Observation?
暂无分享,去创建一个
Min Jung Kim | H. Moon | J. H. Yoon | Soo-Yeon Kim | J. Koo | Hye Sun Lee | Eun-Kyung Kim
[1] Short-term follow-up in 6 months is unnecessary for asymptomatic breast lesions with benign concordant results obtained at ultrasonography-guided 14-gauge core needle biopsy. , 2016, American journal of surgery.
[2] S. Raza,et al. Papilloma on Core Biopsy: Excision vs. Observation , 2015, Annals of Surgical Oncology.
[3] F. Hall. Screening mammography guidelines: an alternative proactive approach. , 2014, Radiology.
[4] N. Sneige,et al. Benign papillomas without atypia diagnosed on core needle biopsy: experience from a single institution and proposed criteria for excision. , 2013, Clinical breast cancer.
[5] B. Pockaj,et al. Papillary Lesions on Core Breast Biopsy: Excisional Biopsy for All Patients? , 2013, The American surgeon.
[6] S. Ichihara,et al. Uniqueness of ductal carcinoma in situ of the breast concurrent with papilloma: implications from a detailed topographical and histopathological study of 50 cases treated by mastectomy and wide local excision , 2013, Histopathology.
[7] Carol Reynolds,et al. Management of Benign Intraductal Solitary Papilloma Diagnosed on Core Needle Biopsy , 2013, Annals of Surgical Oncology.
[8] Byeong‐Woo Park,et al. Can additional immunohistochemistry staining replace the surgical excision for the diagnosis of papillary breast lesions classified as benign on 14-gage core needle biopsy? , 2013, Breast Cancer Research and Treatment.
[9] D. Chan,et al. Papillary breast lesions diagnosed by core biopsy require complete excision. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[10] S. Bose,et al. Intraductal Papillary Lesions of the Breast: Clinical and Pathological Correlation , 2012, The American surgeon.
[11] A. Oga,et al. Combined evaluation of CK5/6, ER, p63, and MUC3 for distinguishing breast intraductal papilloma from ductal carcinoma in situ , 2012, Pathology international.
[12] S. Gabram,et al. Management of papillary breast lesions diagnosed on core-needle biopsy: clinical pathologic and radiologic analysis of 276 cases with surgical follow-up. , 2012, Journal of the American College of Surgeons.
[13] W. Cheng,et al. Nonmalignant Breast Papillary Lesions at Core-Needle Biopsy: A Meta-analysis of Underestimation and Influencing Factors , 2012, Annals of Surgical Oncology.
[14] J. Youk,et al. US-Guided Vacuum-Assisted Percutaneous Excision for Management of Benign Papilloma Without Atypia Diagnosed at US-Guided 14-Gauge Core Needle Biopsy , 2012, Annals of Surgical Oncology.
[15] US follow-up protocol in concordant benign result after US-guided 14-gauge core needle breast biopsy , 2012, Breast Cancer Research and Treatment.
[16] Concordant or Discordant? Imaging-Pathology Correlation in a Sonography-Guided Core Needle Biopsy of a Breast Lesion , 2011, Korean journal of radiology.
[17] Lonie R. Salkowski,et al. Utility of 6-month follow-up imaging after a concordant benign breast biopsy result. , 2011, Radiology.
[18] J. Youk,et al. Benign papilloma without atypia diagnosed at US-guided 14-gauge core-needle biopsy: clinical and US features predictive of upgrade to malignancy. , 2011, Radiology.
[19] D. Georgian-Smith,et al. Controversies on the management of high-risk lesions at core biopsy from a radiology/pathology perspective. , 2010, Radiologic clinics of North America.
[20] J. Youk,et al. Atypical papilloma diagnosed by sonographically guided 14-gauge core needle biopsy of breast mass. , 2010, AJR. American journal of roentgenology.
[21] H. Kang,et al. Risk Factors for Malignancy in Benign Papillomas of the Breast on Core Needle Biopsy , 2010, World Journal of Surgery.
[22] A. Mulligan,et al. Cytokeratin 5 and Estrogen Receptor Immunohistochemistry as a Useful Adjunct in Identifying Atypical Papillary Lesions on Breast Needle Core Biopsy , 2009, The American journal of surgical pathology.
[23] F. Tavassoli,et al. Papillary neoplasms of the breast: a review. , 2009, Archives of pathology & laboratory medicine.
[24] T. Rissanen,et al. Ultrasonography-guided core needle biopsy in differential diagnosis of papillary breast tumors , 2009, Acta radiologica.
[25] C. Chen,et al. Risk Factors Associated with Conversion from Nonmalignant to Malignant Diagnosis After Surgical Excision of Breast Papillary Lesions , 2009, Annals of Surgical Oncology.
[26] S. Jaffer,et al. Excision is indicated for intraductal papilloma of the breast diagnosed on core needle biopsy , 2009, Cancer.
[27] S. Raza,et al. Management of Intraductal Papillomas of the Breast: An Analysis of 129 Cases and Their Outcome , 2009, Annals of Surgical Oncology.
[28] S. T. Chen,et al. The management of papillary lesion of the breast by core needle biopsy. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[29] R. Rouzier,et al. Risk of breast cancer associated with papilloma. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[30] E. Cho,et al. Is surgical excision necessary in benign papillary lesions initially diagnosed at core biopsy? , 2008, Breast.
[31] Jean B. Cormack,et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. , 2008, JAMA.
[32] Min Jung Kim,et al. Nonmalignant papillary lesions of the breast at US-guided directional vacuum-assisted removal: a preliminary report , 2008, European Radiology.
[33] G. Gong,et al. Papillary lesions of the breast diagnosed at percutaneous sonographically guided biopsy: comparison of sonographic features and biopsy methods. , 2008, AJR. American journal of roentgenology.
[34] M. Buchanan,et al. Benign Papilloma on Core Biopsy Requires Surgical Excision , 2008, Annals of Surgical Oncology.
[35] T. Helbich,et al. Probably benign breast masses at US: is follow-up an acceptable alternative to biopsy? , 2007, Radiology.
[36] Eun Sook Ko,et al. Korea. Address reprint requests to: , 2005 .
[37] A. Mulligan,et al. Papillary Lesions of the Breast: A Review , 2007, Advances in anatomic pathology.
[38] D. Vanel. The American College of Radiology (ACR) Breast Imaging and Reporting Data System (BI-RADS): a step towards a universal radiological language? , 2007, European journal of radiology.
[39] N. Dallimore,et al. Immunohistochemistry increases the accuracy of diagnosis of benign papillary lesions in breast core needle biopsy specimens , 2006, Histopathology.
[40] J. Cangiarella,et al. Papillary lesions of the breast at percutaneous core-needle biopsy. , 2006, Radiology.
[41] I. Haigh,et al. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast , 2005, Histopathology.
[42] S. N. Agoff,et al. Papillary lesions of the breast with and without atypical ductal hyperplasia: can we accurately predict benign behavior from core needle biopsy? , 2004, American journal of clinical pathology.
[43] K. Cooper,et al. Immunostaining patterns of myoepithelial cells in breast lesions: a comparison of CD10 and smooth muscle myosin heavy chain , 2004, Journal of Clinical Pathology.
[44] N. Sneige,et al. Accuracy of core needle biopsy diagnosis in assessing papillary breast lesions: histologic predictors of malignancy , 2004, Modern Pathology.
[45] L. Liberman,et al. Breast imaging reporting and data system (BI-RADS). , 2002, Radiologic clinics of North America.
[46] G. Sakorafas. Nipple discharge: current diagnostic and therapeutic approaches. , 2001, Cancer treatment reviews.
[47] E. Sickles. Probably benign breast lesions: when should follow-up be recommended and what is the optimal follow-up protocol? , 1999, Radiology.
[48] K Y Liang,et al. Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.
[49] W. Youden,et al. Index for rating diagnostic tests , 1950, Cancer.